Green synthesis of Se/Ru alloy nanoparticles using gallic acid and evaluation of theiranti-invasive effects in HeLa cells
Source abstract
Abstract
Methods for the synthesis of nanoparticles (NPs) for biomedical applications ideally involve the use of nontoxic reducing and capping agents, and more importantly, enable control over the shape and size of the particles. As such, we used gallic acid (GA) as both a reducing and a capping agent in a simple and "green" synthesis of stable Se/Rualloy NPs (GA-Se/RuNPs). The diameter and morphology of the Se/Ru alloy NPs were regulated by GA concentration, and the presence of Ru was found to be a key factor in regulating and controlling the size of GA-Se/RuNPs. Moreover, GA-Se/RuNPs suppressed HeLa cell proliferation through the induction of apoptosis at concentrations that were nontoxic in normal cells. Furthermore, GA-Se/RuNPs effectively inhibited migration and invasion in HeLa cells via the inhibition of MMP-2 and MMP-9 proteins. Our findings confirm that bimetallic (Se/Ru) NPs prepared via GA-mediated synthesis exhibit enhanced anticancer effects.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Selenium in Biological Systems · Moringa oleifera research and applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment10.1016/j.ctrv.2012.02.003 ↗
2. The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling10.1016/j.biomaterials.2012.09.031 ↗
3. Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranosticse-a see and treat strategy10.1021/nn301633m ↗
4. The use of pH-sensitive functional selenium nanoparticles shows enhanced in vivo VEGF-siRNA silencing and fluorescence imaging10.1039/C4NR02423K ↗
5. Functional selenium nanoparticles enhanced stem cell osteoblastic differentiation through BMP signaling pathways10.1002/adfm.201401263 ↗
6. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice10.1016/j.freeradbiomed.2007.02.013 ↗
7. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion10.1016/j.jnutbio.2007.02.005 ↗
8. Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles10.1016/j.biomaterials.2013.11.007 ↗
9. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s disease10.1016/j.actbio.2015.06.035 ↗
10. Role of proteins in controlling selenium nanoparticle size10.1088/0957-4484/22/19/195605 ↗
11. Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract10.1016/j.colsurfb.2014.08.018 ↗
12. A caffeic acid mediated facile synthesis of silver nanoparticles withpowerful anti-cancer activity10.1016/j.colsurfb.2015.06.070 ↗
13. One-pot, green synthesis of gold nanoparticles by gelatin andinvestigation of their biological effects on Osteoblast cells10.1016/j.colsurfb.2015.05.009 ↗
14. Green synthesis of silver and gold nanoparticles employing levan a biopolymer from Acetobacter xylinum NCIM 2526, as a reducing agent and capping agent10.1016/j.carbpol.2014.06.033 ↗
15. Green nanotechnologies: synthesis of metal nanoparticles using plants10.32607/20758251-2014-6-1-35-44 ↗
16. Biogenic gold nanotriangles from Saccharomonospora sp., an endophytic actinomycetes of Azadirachta indica A. Juss10.1186/2228-5326-3-21 ↗
17. Pheno-lic acid derivatives with potential anticancer properties-a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids10.1016/j.bmc.2004.04.026 ↗
18. Autoxidation of gallic acid induces ROS-dependent death in human prostate cancer LNCaP cells
19. Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells10.1002/jbt.21575 ↗
20. Role of reactive oxygen species in gallic acid-induced apoptosis10.1248/bpb.23.1153 ↗
21. In vitro and in vivo activity of gallic acid and Toona sinensis leaf extracts against HL-60 human premyelocytic leukemia10.1016/j.fct.2012.06.046 ↗
22. Au-Ag@Au hollow nanostructure with enhanced chemical stability and improved photothermal transduction efficiency for cancer treatment10.1021/acsami.5b08305 ↗
23. Formation of metal selenide and metal-selenium nanoparticles using distinct reactivity between selenium and noble metals10.1002/asia.201500191 ↗
24. The formation mechanism of bimetallic PtRu alloy nanoparticles in solvothermal synthesis10.1039/C5NR04459F ↗
25. Se/Ru nanoparticles as inhibitors of metal-induced Aβ aggregation in Alzheimer’s disease10.1039/C3TB21586E ↗
26. Inhibition of tumor growth and vasculature and fluorescence imaging using functionalized ruthenium-thiol protected selenium nanoparticles10.1016/j.biomaterials.2013.11.007 ↗
27. Polypyridyl complexes of ruthenium(ii): stabilization of G-quadruplex DNA and inhibition of telomerase activity10.1002/cplu.201200039 ↗
28. Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways10.1039/C3MT00237C ↗
29. Surface decoration of selenium nanoparticles by mushroom polysaccharides-protein complexes to achieve enhanced cellular uptake and antiproliferative activity10.1039/c2jm16828f ↗
30. Cancer cell invasion: treatment and monitoring opportunities in nanomedicine10.1016/j.addr.2011.01.010 ↗
31. Uterine cervical carcinoma: role of matrix metalloproteinases (review)10.3892/ijo_00000215 ↗
32. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras10.1097/CMR.0b013e3283414444 ↗
33. Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways10.1016/j.fct.2012.02.033 ↗
34. Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl10.1002/mnfr.201200167 ↗
35. Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9m10.3892/or.2014.3209 ↗
36. Biosynthesis and recovery of selenium nanoparticles and the effects on matrix metalloproteinase-2 expression10.1042/BA20100042 ↗